Abstract
Successfully incorporating genetic testing into clinical practice to prevent sudden cardiac death (SCD) requires (1)appropriate recognition of an inherited cardiovascular condition, (2)identification of appropriate family members at risk and for genetic testing, (3)selection of the appropriate genetic test and information about the expected diagnostic yield, (4)understanding the complexity of result interpretation and distinct handling of incidental findings and (5)providing effective communication and medical advice regarding the genetic and medical results and implications to the patient and his family. Molecular autopsy in SCD victims will be of future importance to determine the cause of death. Interdisciplinary patient care should be provided in specialized centers with ahigh level of cardiogenetic expertise and is recommended to provide precise and individualized patient management.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
